Skip to menu Skip to content Skip to footer
Dr Christine Staatz
Dr

Christine Staatz

Email: 
Phone: 
+61 7 334 61974

Overview

Background

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

  • Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
  • Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
  • Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
  • Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
  • Improving gentamycin dosing in paediatric oncology patients
  • Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
  • Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
  • Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

  • Dose optimisation of busulfan in paediatric bone marrow transplant recipients
  • Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
  • Examining Bayesian forecasting methods to predict immunosuppressant exposure
  • Examining the international use of immunosuppressant and anti-rheumatic drugs
  • Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

  • PHRM3052- Biological Fate of Drugs

Teaches in:

  • PHRM3052- Biological Fate of Drugs
  • PHRM3011- Quality Use of Medicines

Availability

Dr Christine Staatz is:
Available for supervision

Qualifications

  • Bachelor, The University of Queensland
  • Bachelor (Honours) of Pharmacy, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Christine Staatz’s works on UQ eSpace

254 works between 1998 and 2025

221 - 240 of 254 works

2006

Conference Publication

Conditional weighted residuals, an improved model diagnostic for the FO/FOCE methods

Hooker, A., Staatz, C E and Karlsson, M. (2006). Conditional weighted residuals, an improved model diagnostic for the FO/FOCE methods. Annual Meeting of the Population Approach Group in Europe, Brugge Belgium, 14-16 June 2006. Belgium: Population Approach Group in Europe.

Conditional weighted residuals, an improved model diagnostic for the FO/FOCE methods

2006

Journal Article

Population pharmacokinetic modeling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery

Staatz, Christine E., Byrne, Colette and Thomson, Alison H. (2006). Population pharmacokinetic modeling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery. British Journal of Clinical Pharmacology, 61 (2), 164-176. doi: 10.1111/j.1365-2125.2005.02547.x

Population pharmacokinetic modeling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery

2006

Conference Publication

Predictors of new onset diabetes after renal transplantation

Joss, N., Staatz, C., Thomson, A. and Jardine, A. G. (2006). Predictors of new onset diabetes after renal transplantation. Annual Meeting of the Scottish Cardiac Society, Turnberry, Scotland, November 2006. GLASGOW: SCOTTISH MEDICAL JOURNAL.

Predictors of new onset diabetes after renal transplantation

2006

Journal Article

Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients

Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2006). Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients. Journal of Clinical Pharmacy And Therapeutics, 31 (1), 17-25. doi: 10.1111/j.1365-2710.2006.00697.x

Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients

2006

Conference Publication

Predictors of new onset diabetes after renal transplantation

Joss, N., Staatz, C. E., Thomson, A. and Jardine, A. G. (2006). Predictors of new onset diabetes after renal transplantation. Annual Meeting of the Scottish Cardiac Society, Turnberry Hotel, Ayrshire Scotland, November 2005. Scotland: Scottish Renal Association.

Predictors of new onset diabetes after renal transplantation

2005

Journal Article

Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation

Staatz, Christine E., Duffull, Stephen B., Kiberd, Bryce, Fraser, Albert D. and Tett, Susan E. (2005). Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. European Journal of Clinical Pharmacology, 61 (7), 507-516. doi: 10.1007/s00228-005-0927-4

Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation

2005

Conference Publication

Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiac surgery

Staatz, CE, Byrne, C and Thomson, AH (2005). Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiac surgery. 9th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Louisville KY, APR 23-28, 2005. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00007691-200504000-00079

Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiac surgery

2005

Journal Article

Pharmacokinetic considerations relating to tacrolimus dosing in the elderly

Staatz, C. E. and Tett, S. E. (2005). Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs & Aging, 22 (7), 541-557. doi: 10.2165/00002512-200522070-00001

Pharmacokinetic considerations relating to tacrolimus dosing in the elderly

2005

Journal Article

Tacrolimus in patients with rheumatoid arthritis - A viewpoint by Christine Staatz

Staatz, C (2005). Tacrolimus in patients with rheumatoid arthritis - A viewpoint by Christine Staatz. Drugs, 65 (7), 1003-1003.

Tacrolimus in patients with rheumatoid arthritis - A viewpoint by Christine Staatz

2004

Journal Article

A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation

Staatz, Christine E., Taylor, Paul J., Lynch, Stephen V. and Tett, Susan E. (2004). A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transplantation, 10 (4), 506-512. doi: 10.1002/lt.20065

A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation

2004

Conference Publication

Evaluation of a population pharmacokinetic model for gentamicin in patients with unstable renal function following cardiac surgery

Staatz, C. E., Byrne, C. and Thomson, A. H. (2004). Evaluation of a population pharmacokinetic model for gentamicin in patients with unstable renal function following cardiac surgery. PKUK conference, Belfast, Ireland, November 2004.

Evaluation of a population pharmacokinetic model for gentamicin in patients with unstable renal function following cardiac surgery

2004

Journal Article

Sampling times for monitoring tacrolimus in stable adult liver transplant recipients

Dansirikul, C, Staatz, CE, Duffull, SB, Taylor, PJ, Lynch, SV and Tett, SE (2004). Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Therapeutic Drug Monitoring, 26 (6), 593-599. doi: 10.1097/00007691-200412000-00003

Sampling times for monitoring tacrolimus in stable adult liver transplant recipients

2004

Journal Article

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

Staatz, C. E. and Tett, S. E. (2004). Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clinical Pharmacokinetics, 43 (10), 623-653. doi: 10.2165/00003088-200443100-00001

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

2003

Journal Article

Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients

Willis, Charlene, Staatz, Christine E. and Tett, Susan E. (2003). Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients. Therapeutic Drug Monitoring, 25 (2), 158-166. doi: 10.1097/00007691-200304000-00004

Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients

2003

Conference Publication

Pharmacodynamic investigations of tacrolimus in liver transplantation

Staatz, C. E., Dansirikul, C., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2003). Pharmacodynamic investigations of tacrolimus in liver transplantation. TSANZ 21st Annual Scientific Meeting, Canberra, 9-11 April 2003. Canberra: TSANZ. doi: 10.1046/j.1440-1711.2003.00812.x

Pharmacodynamic investigations of tacrolimus in liver transplantation

2003

Conference Publication

Pharmacodynamics of tacrolimus in pediatric liver transplantation

Staatz, C. E., TaylorPJ, LynchSV, TettSE, SSoldin and FSjoeqvist (2003). Pharmacodynamics of tacrolimus in pediatric liver transplantation. 8th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Basel, Switzerland, 7-11 September, 2003. New York: Lippincott-Raven.

Pharmacodynamics of tacrolimus in pediatric liver transplantation

2003

Conference Publication

Detecting drug interactions associated with tacrolimus

Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Detecting drug interactions associated with tacrolimus. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:

Detecting drug interactions associated with tacrolimus

2003

Journal Article

Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation

Staatz, Christine E., Willis, Charlene, Taylor, Paul J, Lynch, Stephen V. and Tett, Susan E. (2003). Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transplantation, 9 (2), 130-137. doi: 10.1053/jlts.2003.50023

Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation

2003

Conference Publication

Limited sampling strategies for monitoring tacrolimus in liver transplant recipients

Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Limited sampling strategies for monitoring tacrolimus in liver transplant recipients. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:

Limited sampling strategies for monitoring tacrolimus in liver transplant recipients

2002

Journal Article

Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus

Staatz, Christine E. and Tett, Susan E. (2002). Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus. European Journal of Clinical Pharmacology, 58 (9), 597-605. doi: 10.1007/s00228-002-0517-7

Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus

Funding

Current funding

  • 2024 - 2026
    Exploring the impact of BUsulfan METabolites on busulfan clearance, exposure and patient outcomes following Haematopoietic Stem Cell Transplantation (BU-MET-HSCT). (QHCRF administered by CHQ HHS)
    Children's Health Queensland Hospital and Health Service
    Open grant

Past funding

  • 2019 - 2020
    Evaluating immunosuppressant medicines in elderly renal transplant recipients
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2019
    Bu4DayPK - Analysis of once daily IV Busulfan in paediatric HSCT patients
    Children's Health Queensland Hospital and Health Service
    Open grant
  • 2018 - 2019
    Innovative blood sampling to reduce the burden of long-term treatment for kidney transplant recipients
    Metro North Hospital and Health Service
    Open grant
  • 2014
    Designing optimal dosing regimens for immunosuppressant medications
    Queensland Pharmacy Research Trust
    Open grant
  • 2010 - 2011
    Examining the relationship between immunosuppression and BK virus infection in adult kidney transplant recipients
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2010
    Analytical instrumentation enabling rapid compound separation and chemical structure analysis via mass fingerprinting
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008 - 2011
    Lions Medical Research Foundation Fellowship - Tailoring doses of the newer immunosuppressant drugs to improve outcomes after transplant
    Lions Medical Research Foundation
    Open grant
  • 2008 - 2011
    Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs
    NHMRC Project Grant
    Open grant
  • 2008
    UQ Travel Awards Category 2 - Christine Staatz
    UQ Travel Grants Scheme
    Open grant
  • 2004 - 2008
    NEIL HAMILTON FAIRLEY FELLOWSHIP: Population Pharmacokinetic And Pharmacodynamic Modelling Of The Newer Immunosuppressant Drugs
    NHMRC Training (Postdoctoral) Fellowship
    Open grant

Supervision

Availability

Dr Christine Staatz is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au